 |
PDBsum entry 7n4s
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
7n4s
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Utilizing structure based drug design and metabolic s spot identification to optimize the in vitro potency vivo pharmacokinetic properties leading to the discov novel reversible bruton'S tyrosine kinase inhibitors.
|
|
|
Authors
|
|
B.T.Hopkins,
E.Bame,
N.Bell,
T.Bohnert,
J.K.Bowden-Verhoem.Bui,
M.T.Cancilla,
P.Conlon,
P.Cullen,
D.A.Erlanson,
J.Ft.Fuchs-Knotts,
S.Hansen,
S.Heumann,
T.J.Jenkins,
C.Gua,
Yy.Liu,
M.Lulla,
D.Marcotte,
I.Marx,
B.Mcdowell,
E.Mertschie.Negrou,
M.J.Romanowski,
D.Scott,
L.Silvian,
W.Yang,
M.Zh.
|
|
|
Ref.
|
|
bioorg med chem, 2021,
44,
16275.
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
